Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease

National Medical Journal of China

Volumn 85, Issue 38, 2005, Pages 2691-2695

  Wang, Tao ^a   Li, Shuo Xian ^b   Zhang, Xi Quan ^b   Gu, Xing Hua ^b   Song, Yi ^b   Zhang, Gong ^b   Wu, Shu Ming ^b  

^a SHANDONG UNIVERSITY   (China)

^b NONE

Author keywords

Adrenomedulin; Heart defects, congenital; Hypertension, pulmonary; Urotensin II

Indexed keywords

ADRENOMEDULLIN; UROTENSIN II;

ADULT; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEART SURGERY; HUMAN; LUNG ARTERY PRESSURE; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULMONARY HYPERTENSION; RADIOIMMUNOASSAY; RELIABILITY; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADRENOMEDULLIN; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; UROTENSINS; YOUNG ADULT;

EID: 27644433921     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedulin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun, 1993, 192:553-560.
2. Coulouarn Y, Librman I, Jegou S, et al. Cloning of cDNA encoding the urotensin- II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA, 1998, 95:15803-15808.
3. Stirrat A, Gallagher M, Douglas SA, et al. Potent vasodilator responses to human urotensin- II in human pulmonary and abdominal resistance arteries. Am J Heart Circ Physiol, 2001, 280:925-928.
4. Rabinnovitch M, Bothwell T, Hayakawa BN, et al. Pulmonary artery endothelial abnormalities in patients with congenital heart defect and pulmonary hypertension: a correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest, 1986, 55:632-653.
5. 2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Circulation, 1993, 88:2117-2122.
6. Penny WF, Weinstein M, Salsman EW, et al. Correlation of circulating von willebrand factor levels with cardiovascular hemodynamics. Circulation, 1991, 83:1630-1636.
7. Jougasaki M, Burnett JC. Adrenomedulin: Potential in physiology and pathophysiology. Life Sci, 2000, 66:855-872.
8. Nakamura M, Yoshika H, Makita S, et al. The various biological effects of adrenomedulin. Circulation, 1997, 95:1214-1221.
9. Kahno M, Kano H, Horio T, et al. The antiproliferative action of adrenomedulin for arterial smooth muscle cell in mouse. Hypertension, 1995, 25:1185-1190.
10. Kahno M, Yokokawa K, Yasunari K, et al. Induction by lysophosphati-dylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation, 1998, 98:353-359.
11. Vijay P, Szekely L, Sharp TG, et al. The change of adrenomedulin before and after operation on patients with congenital heart disease and pulmonary hypertension. Ann Thorac Surg, 1998, 66:500-505.
12. Zhao L, Borwn LA, Owji AA, et al. Adrenomedullin activity in chronically hypoxic rat lungs. Phsiol, 1996, 271:622-626.
13. Conlon JM, Yano K, Wagh D, et al. Distribution and molecular forms of urotensin- II and its role in cardiovascular regulation in vertebrates. J Exp Zool, 1996, 275:226-238.
14. Liu GQ, Zeng ZP, Li HZ, et al. Expression of urotensin II mRNA in normal adrenal medulla and pheochro mocytoma tissues. Natl Med J China, 2003,83:1225-1228.